Supplementary Figure from Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors

Emerson A. Lim,Johanna C. Bendell,Gerald S. Falchook,Todd M. Bauer,Charles G. Drake, Jennifer H. Choe,Daniel J. George, Janet L. Karlix,Susanna Ulahannan, Kris F. Sachsenmeier, Deanna L. Russell, Ganesh Moorthy,Ben S. Sidders, Elizabeth A. Pilling,Huifang Chen,Maureen M. Hattersley, Mayukh Das,Rakesh Kumar,Gayle P. Pouliot,Manish R. Patel

crossref（2023）

引用 0|浏览0

暂无评分

摘要

Supplementary Figure from Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要